Norfloxacin – restriction change reminder

Medicines Decision

PHARMAC is reminding clinicians and pharmacists that from 1 July 2014 the restriction applying to norfloxacin tablets in the community will be amended as follows (deletions in strikethrough, additions in bold):

Maximum of 6 tab per prescription; can be waived by endorsement - Retail pharmacy - Specialist.

Subsidy by endorsement

Only if prescribed for a patient with an uncomplicated urinary tract infection that is unresponsive to a first line agent or with proven resistance to first line agents and the prescription is endorsed accordingly.

This was the subject of a consultation letter dated 25 September 2012 [PDF, 533 KB] and a notification letter dated 19 March 2013 [PDF, 142 KB].

PHARMAC agreed to delay the implementation of this decision to 1 July 2014 as at the time of the decision norfloxacin was supplied under a Tender agreement and the decision could have impacted on the supplier.

More information

If you have any questions about this decision, you can email us at or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.